GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 355 filers reported holding GUARDANT HEALTH INC in Q1 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,346 | -17.4% | 1,125 | -0.2% | 0.00% | – |
| Q2 2023 | $40,347 | +43.8% | 1,127 | -5.8% | 0.00% | – |
| Q1 2023 | $28,058 | +382.0% | 1,197 | +459.3% | 0.00% | – |
| Q4 2022 | $5,821 | -70.9% | 214 | -41.2% | 0.00% | – |
| Q3 2022 | $20,000 | +33.3% | 364 | +1.7% | 0.00% | – |
| Q2 2022 | $15,000 | -75.4% | 358 | -61.5% | 0.00% | – |
| Q1 2022 | $61,000 | -54.1% | 930 | -30.0% | 0.00% | – |
| Q4 2021 | $133,000 | +533.3% | 1,328 | +700.0% | 0.00% | – |
| Q3 2021 | $21,000 | 0.0% | 166 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | +23.5% | 166 | +48.2% | 0.00% | – |
| Q1 2021 | $17,000 | +13.3% | 112 | -6.7% | 0.00% | – |
| Q4 2020 | $15,000 | +15.4% | 120 | +7.1% | 0.00% | – |
| Q3 2020 | $13,000 | +225.0% | 112 | +100.0% | 0.00% | – |
| Q1 2020 | $4,000 | +33.3% | 56 | +75.0% | 0.00% | – |
| Q2 2019 | $3,000 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |